As drug development enters a new era, Certara is expanding its global team of scientists and technologists to lead the shift toward AI-powered testing methods.

From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance cellular reprogramming for aging research. The company operates across ...

Drug resistance remains the foremost challenge to durable cancer control. Tumors evolve dynamic mechanisms to evade therapy through target mutations, ...

Chemical processes and multiscale modeling approaches have become vital to the advancement of thermal protection systems (TPS) designed for supersonic and ...

Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the ...

New York Times columnist David Brooks and Kimberly Atkins Stohr of the Boston Globe join Geoff Bennett to discuss the week in politics, including the demolition of ...